Overview

A Study to Investigate the Safety and Efficacy of TMP-301 Compared to Placebo in Adult Patients With Alcohol Use Disorder

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2025-11-15
Target enrollment:
Participant gender:
Summary
TMP-301 has been shown in preclinical models to reduce consumption of alcohol and other addictive substances. It has been tested in healthy subjects and has been found to be safe and tolerated at doses predicted to be efficacious in alcohol use disorder. This study is being conducted to evaluate the safety, tolerability and efficacy of TMP-301 in patients with alcohol use disorder.
Phase:
PHASE2
Details
Lead Sponsor:
Tempero Bio, Inc.